Cancer Treatment in CKD: Time to Move Beyond Renalism
- PMID: 37768807
- PMCID: PMC10547220
- DOI: 10.34067/KID.0000000000000258
Cancer Treatment in CKD: Time to Move Beyond Renalism
Conflict of interest statement
M.A. Vazquez reports the following: Advisory or leadership role: Advisory Committee UTSouthwestern Health Systems-DaVita Dialysis Joint Venture. The remaining author has nothing to disclose.
Comment on
-
Kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line Treatment of Metastatic Urothelial Carcinoma.Kidney360. 2023 Sep 1;4(9):e1203-e1211. doi: 10.34067/KID.0000000000000214. Epub 2023 Jul 18. Kidney360. 2023. PMID: 37461133 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical